JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
40 hedge funds and large institutions have $19.9M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
40
Holding in Top 10
–
Calls
$12K
Puts
–
Top Buyers
| 1 | +$305K | |
| 2 | +$100K | |
| 3 | +$27.1K | |
| 4 |
AG
Algert Global
San Francisco,
California
|
+$24.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.4K |
Top Sellers
| 1 | -$247K | |
| 2 | -$201K | |
| 3 | -$155K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$73K |
| 5 |
Bank of New York Mellon
New York
|
-$59K |